LFST
Lifestance Health Group Inc
Lifestance Health Group Inc historical holders
total: 1
Durable Capital Partners Lifestance Health Group Inc transactions over time
- Total transactions:
- 11
- New positions:
- 2
- Sold out:
- 2
- Added:
- 4
- Reduced:
- 3
- Held since:
- 2023 Q2
- Held for:
- 7 quarters
- Latest activity:
- 2025 Q1
Henry Ellenbogen has been an institutional investor in Lifestance Health Group Inc (LFST) since 2021 Q2. According to 2026 Q2 report, Henry Ellenbogen doesn't hold any shares. The fund/company first acquired LFST in 2021 Q2, initially purchasing about 1.50M shares. Henry Ellenbogen later completely sold out the position and reinvested in LFST again in 2023 Q2. Since the initial investment, Durable Capital Partners has made 10 more transactions in this position.
When did Henry Ellenbogen exit their LFST position?
Henry Ellenbogen no longer holds Lifestance Health Group Inc (LFST). They sold off their entire position in 2025 Q1, closing out an investment that began in 2021 Q2.
When did Henry Ellenbogen first invest in LFST?
Henry Ellenbogen first invested in Lifestance Health Group Inc (LFST) in 2021 Q2 at the reported quarter-end price of $27.86 per share, acquiring 1,500,000 shares in their initial purchase.
What is Henry Ellenbogen's average cost basis for LFST?
Based on historical transaction data, Henry Ellenbogen's estimated cost basis for Lifestance Health Group Inc (LFST) is approximately $7.04 per share. This represents their average reported price* across all buy transactions.
Has Henry Ellenbogen reinvested in LFST after selling?
Yes, Henry Ellenbogen has shown renewed interest in Lifestance Health Group Inc (LFST). After completely selling their position, they reinitiated an investment in 2023 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $7.04
- Weighted AVG sell price:
- $7.31
LFST transactions history by Durable Capital Partners
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q1
|
0.00%
|
0
|
$7.37
|
|
-100% (-9,508,826)
|
-0.57%
|
|
2024 Q4
|
0.57%
|
9,508,826
|
$7.37
|
$70,080,048
|
-8.93% (-932,242)
|
-0.05%
|
|
2024 Q3
|
0.53%
|
10,441,068
|
$7.00
|
$73,087,476
|
-15.76% (-1,954,017)
|
-0.11%
|
|
2024 Q2
|
0.50%
|
12,395,085
|
$4.91
|
$60,859,867
|
+19.70% (+2,040,123)
|
+0.08%
|
|
2024 Q1
|
0.50%
|
10,354,962
|
$6.17
|
$63,890,116
|
+36.29% (+2,757,443)
|
+0.13%
|
|
2023 Q4
|
0.47%
|
7,597,519
|
$7.83
|
$59,488,574
|
+426.07% (+6,153,312)
|
+0.38%
|
|
2023 Q3
|
0.09%
|
1,444,207
|
$6.87
|
$9,921,702
|
+53.13% (+501,092)
|
+0.03%
|
|
2023 Q2
|
0.08%
|
943,115
|
$9.13
|
$8,610,640
|
new
|
+0.08%
|
|
2021 Q4
|
0.00%
|
0
|
$14.50
|
|
-100% (-1,325,747)
|
-0.15%
|
|
2021 Q3
|
0.15%
|
1,325,747
|
$14.50
|
$19,223,000
|
-11.62% (-174,253)
|
-0.02%
|
|
2021 Q2
|
0.31%
|
$27.86
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.